Skip to main content
BEONE MEDICINES LTD. logo

BEONE MEDICINES LTD. — Investor Relations & Filings

Ticker · 688235 ISIN · CNE100005XT6 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 728 across all filing types
Latest filing 2023-09-14 Board/Management Inform…
Country CN China
Listing Shanghai Stock Exchange 688235

About BEONE MEDICINES LTD.

https://beonemedicines.com/

BEONE MEDICINES LTD. is a biopharmaceutical company focused on the research, development, and commercialization of innovative therapeutic solutions, primarily in the field of oncology. The company specializes in the discovery of targeted small molecule drugs and biologics designed to address unmet medical needs in cancer treatment. Its research and development pipeline emphasizes precision medicine, utilizing advanced molecular biology and medicinal chemistry platforms to identify novel drug candidates. BEONE MEDICINES LTD. aims to improve patient outcomes by developing high-efficacy, low-toxicity therapies that target specific genetic drivers of disease. The company maintains a strong focus on clinical-stage development and strategic collaborations to advance its portfolio of next-generation medicines.

Recent filings

Filing Released Lang Actions
港股公告：董事名单及其角色与职能
Board/Management Information Classification · 95% confidence The document lists the members of the board of directors and their roles and committee memberships. It includes details about executive, non-executive, and independent non-executive directors, as well as their committee assignments. There is no financial data, no mention of a report being attached or published, and no indication of a meeting or voting results. The content is focused on board and management information, specifically the composition and structure of the board and its committees. Therefore, the document fits the category of Board/Management Information (MANG). The document length is short (1070 characters), but it is not an announcement of a report publication or a certification. Hence, the classification is MANG with high confidence.
2023-09-14 Chinese
百济神州有限公司关于董事会审计委员会主席变更的公告
Board/Management Information Classification · 100% confidence The document is a short announcement regarding a change in the company's board committee leadership, specifically the appointment of a new chairman of the audit committee. It does not contain financial data, audit results, or detailed reports. The content fits the category of Board/Management Information, as it announces changes in the company's board or senior management roles. The document length is only 510 characters, confirming it is a brief announcement rather than a full report.
2023-09-14 Chinese
港股公告：员工购股计划
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the company's 2018 Employee Stock Purchase Plan (ESPP), detailing the subscription period, eligibility, purchase price, and other plan specifics. It is a regulatory announcement about a capital-related employee benefit plan, not a financial report or earnings release. The document is relatively short (2733 characters) and does not contain financial statements or detailed financial analysis. It is not a report publication announcement but a formal disclosure under listing rules about the employee stock purchase plan. This fits best under Capital/Financing Update (CAP) as it relates to company financing activities through employee share purchases.
2023-09-07 Chinese
港股公告：证券变动月报表
Regulatory Filings Classification · 95% confidence The document is a monthly securities movement report for a listed issuer and its Hong Kong Depositary Receipt issuer under Chapter 19B of the Listing Rules. It details changes in registered capital, issued shares, share options, and confirmations related to share issuance and compliance with listing rules. The document is structured as a regulatory monthly report on share capital and securities movements, submitted to the Hong Kong Stock Exchange. It is not an annual or interim financial report, nor an earnings release or management discussion. It is not a proxy, voting result, or AGM material. It is a regulatory filing specifically about share capital changes and securities movements, consistent with the category of Regulatory Filings (RNS). The document length is 4734 characters, which is substantive and contains detailed data, not just an announcement of a report publication. Therefore, the best classification is Regulatory Filings (RNS).
2023-09-07 Chinese
港股公告：授出购股权及受限制股份单位
Transaction in Own Shares Classification · 95% confidence The document is a formal announcement from BeiGene, Ltd. regarding the grant of share options and restricted share units under the 2016 Option and Incentive Plan. It details the number of shares/options granted, exercise prices, vesting schedules, and related terms. The text references compliance with listing rules and provides definitions related to the share plan. There is no financial statement or comprehensive financial data presented. The document is a regulatory announcement about share-based compensation grants to employees, which fits the category of Director's Dealing or related insider share transactions. However, since the recipients are employees and not directors or senior management, and the document is about share option grants, it aligns best with a Transaction in Own Shares (POS) filing, which covers share repurchases or issuances including share option grants. The document is relatively short (3440 characters) and is a direct announcement of share option grants, not a report or presentation. Therefore, the most appropriate classification is POS (Transaction in Own Shares).
2023-09-07 Chinese
港股公告：证券变动月报表
Regulatory Filings Classification · 95% confidence The document is a monthly securities movement report for a listed issuer and its Hong Kong Depositary Receipt issuer under Chapter 19B of the Listing Rules. It details changes in registered capital, issued shares, share options, and confirmations related to share issuance and compliance with listing rules. The document is structured as a regulatory monthly report on share capital and securities movements, submitted to the Hong Kong Stock Exchange. It does not contain financial statements, earnings data, or management discussion, nor is it an announcement of voting results or a proxy solicitation. It is a regulatory filing specific to share capital changes and securities movements, fitting the category of Regulatory Filings (RNS). The document length is about 4809 characters, which is consistent with a detailed regulatory filing rather than a brief announcement or a full annual/interim report.
2023-09-07 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.